UBC Medical Indonesia Tbk. vs Bank Multiarta Sentosa Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Bank Multiarta Sentosa Tbk. trades at Rp3,390 (market cap 4.7T, 10.8K 24h volume). The key difference: Bank Multiarta Sentosa Tbk. is far larger — about 8.1× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 10.8K). Which is the better fit depends on your goals.
| LABS | MASB | |
|---|---|---|
Market Cap | 576.7B | 4.7T |
Volume | 3.48M | 10.8K |
Lot | 34.82K | 108 |
Turnover | 522.79M | 36.52M |
Average Price | 150.13 | 3,381.85 |
Value | 522.79M | 36.52M |
Indicative Equilibrium Price | 148 | — |
Indicative Equilibrium Volume | 350 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Bank Multiarta Sentosa Tbk (the Bank) was established by Deed No.201 dated July 28, 1992 of H.Saidus Sjahar, S.H. The Bank's parent company is PT Danabina Sentana which is the majority stockholder of the Bank. The majority shareholder of PT Danabina Sentana is PT Lumbung Artakencana which is a company established in Indonesia and the Bank’s ultimate shareholder that joined in business group of Wings Group.
Read more on MASB →